Minimal Sustainability of Dedifferentiation by ROCK Inhibitor on Rat Nucleus Pulposus Cells In Vitro

  • Nukaga Tadashi
    Department of Orthopaedic Surgery, Tokai University School of Medicine
  • Sakai Daisuke
    Department of Orthopaedic Surgery, Tokai University School of Medicine
  • Schol Jordy
    Department of Orthopaedic Surgery, Tokai University School of Medicine
  • Suyama Kaori
    Department of Anatomy and Cellular Biology, Tokai University School of Medicine
  • Nakai Tomoko
    Department of Orthopaedic Surgery, Tokai University School of Medicine
  • Hiyama Akihiko
    Department of Orthopaedic Surgery, Tokai University School of Medicine
  • Watanabe Masahiko
    Department of Orthopaedic Surgery, Tokai University School of Medicine

この論文をさがす

抄録

<p>Introduction: Intervertebral disc degeneration is strongly associated with low back pain. Cell transplantation has been extensively studied as a treatment option for intervertebral disc degeneration. It is often necessary to perform cell culture prior to cell transplantation; however, during cell expansion, the cells tend to dedifferentiate and lose their potency. Although the ability to suppress dedifferentiation by ROCK inhibitor (ROCKi) has recently been reported for chondrocytes, its effects on nucleus pulposus cells are still largely unknown.</p><p>Methods: Rat nucleus pulposus cells were cultured with or without the addition of ROCKi (Y-27632), and cell proliferation; CD24 positivity; expression of SOX9, COL2A1, Aggrecan, and COL1A1; and cell redifferentiation ability in pellet culture were evaluated.</p><p>Results: Although the addition of ROCKi tended to slightly increase the cell proliferative capacity, no significant differences were observed between treated and untreated conditions. The addition of ROCKi showed a trend of minimally increased COL2A1, ACAN, and SOX9 expression. Increases in COL1A1 expression was slightly suppressed by ROCKi. In pellet culture, strong increase in type II collagen deposition was observed by the addition of ROCKi. The addition of ROCKi did not significantly change the levels of CD24 positivity. The supplementation of ROCKi did not significantly enhance nucleus pulposus cell marker expression during monolayer expansion. However, ROCKi addition did result in an increased type II collagen deposition in 3D pellet culture.</p><p>Conclusions: Taken together, the results suggest a minimal effect by ROCKi on nucleus pulposus cell phenotype maintenance.</p>

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (40)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ